Last reviewed · How we verify

NCT04932122

Outcomes After Dorsal Wrist Ganglia Excision With or Without PIN

Terminated NA Last updated 11 February 2026
What this trial tests

NA trial testing Dorsal wrist ganglion alone (DWG) in Wrist Ganglion in 3 participants. Terminated before completion.

Timeline
7 August 2023
Primary endpoint
3 February 2026
3 February 2026

Quick facts

Lead sponsorKenneth Taylor, M.D.
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment3
Start date7 August 2023
Primary completion3 February 2026
Estimated completion3 February 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Kenneth Taylor, M.D.

Who can join

18 and older, any sex, with Wrist Ganglion or Ganglion Cysts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if a statistical significance exists between outcomes of patients treated for dorsal wrist ganglion cyst with excision alone versus excision and the addition of a partial wrist denervation by resecting the common terminal sensory branch of the PIN (posterior interosseus nerve). Our hypothesis is that addition of PIN improves outcome after dorsal wrist ganglion excision as indicated by post-operative pain, function, ability to perform activities of daily living, and physical exam findings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Kenneth Taylor, M.D. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04932122.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing